Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Olema Pharmaceuticals, Inc. (OLMA)
Kovacs Shane William Charles — CH. OPERATING & FINANCIAL OFF.
Shares
3,822
Price
$28.01
Total Value
$107.05K
Shares Held After
239,727
% of Holdings
1.6%
Scholar Rock Holding Corp (SRRK)
Sinha Vikas — Chief Financial Officer
Shares
16,755
Price
$42.70
Total Value
$715.44K
Shares Held After
583,245
% of Holdings
2.8%
Scholar Rock Holding Corp (SRRK)
Woods Keith — Chief Operating Officer
Shares
16,746
Price
$42.70
Total Value
$715.05K
Shares Held After
583,254
% of Holdings
2.8%
Scholar Rock Holding Corp (SRRK)
Vaishnaw Akshay — Director
Shares
20,438
Price
$42.70
Total Value
$872.70K
Shares Held After
595,767
% of Holdings
3.3%
Scholar Rock Holding Corp (SRRK)
Hallal David — Director
Shares
57,450
Price
$42.70
Total Value
$2.45M
Shares Held After
1,541,645
% of Holdings
3.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
7,709
Price
$32.75
Total Value
$252.47K
Shares Held After
61,804
% of Holdings
11.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
43,198
Price
$0.55
Total Value
$23.76K
Shares Held After
2,266,671
% of Holdings
1.9%
Acrivon Therapeutics, Inc. (ACRV)
Devroe Eric — Chief Operating Officer
Shares
10,000
Price
$1.72
Total Value
$17.22K
Shares Held After
75,308
% of Holdings
13.3%
Apellis Pharmaceuticals, Inc. (APLS)
Chopas James George — VP/Chief Accounting Officer
Shares
873
Price
$22.19
Total Value
$19.37K
Shares Held After
52,595
% of Holdings
1.6%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
1,780
Price
$22.19
Total Value
$39.49K
Shares Held After
83,058
% of Holdings
2.1%
Apellis Pharmaceuticals, Inc. (APLS)
Deschatelets Pascal — Chief Scientific Officer
Shares
2,277
Price
$22.19
Total Value
$50.52K
Shares Held After
1,158,219
% of Holdings
0.2%
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
10,186
Price
$22.19
Total Value
$226.00K
Shares Held After
321,419
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
2,618
Price
$22.19
Total Value
$58.09K
Shares Held After
81,046
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
3,856
Price
$22.19
Total Value
$85.55K
Shares Held After
107,080
% of Holdings
3.5%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
5,780
Price
$22.19
Total Value
$128.24K
Shares Held After
98,838
% of Holdings
5.5%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
1,923
Price
$21.08
Total Value
$40.54K
Shares Held After
22,408
% of Holdings
7.9%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
11,663
Price
$20.54
Total Value
$239.55K
Shares Held After
24,331
% of Holdings
32.4%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
4,440
Price
$19.45
Total Value
$86.37K
Shares Held After
35,994
% of Holdings
11.0%
BioAge Labs, Inc. (BIOA)
GOLDSTEIN DOV A MD — Chief Financial Officer
Shares
8,974
Price
$18.43
Total Value
$165.37K
Shares Held After
40,434
% of Holdings
18.2%
BioAge Labs, Inc. (BIOA)
Fortney Kristen — Director
Shares
233,107
Price
$18.12
Total Value
$4.22M
Shares Held After
976,949
% of Holdings
19.3%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
6,609
Price
$19.80
Total Value
$130.89K
Shares Held After
996,502
% of Holdings
0.7%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
5,861
Price
$19.80
Total Value
$116.07K
Shares Held After
882,418
% of Holdings
0.7%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
6,609
Price
$19.80
Total Value
$130.89K
Shares Held After
996,502
% of Holdings
0.7%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
5,861
Price
$19.80
Total Value
$116.07K
Shares Held After
882,418
% of Holdings
0.7%
Immuneering Corp (IMRX)
Neufeld Leah R — CHIEF PEOPLE OFFICER
Shares
2,626
Price
$4.15
Total Value
$10.91K
Shares Held After
25,970
% of Holdings
10.1%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,800
Price
$29.83
Total Value
$53.69K
Shares Held After
5,604,102
% of Holdings
0.0%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
200
Price
$28.49
Total Value
$5.70K
Shares Held After
542,761
% of Holdings
0.0%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
49,800
Price
$27.60
Total Value
$1.37M
Shares Held After
542,961
% of Holdings
8.4%
Omeros Corporation (OMER)
Borges David J. — VP, Finance & CAO
Shares
30,000
Price
$12.31
Total Value
$369.31K
Shares Held After
0
% of Holdings
100.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
122
Price
$374.33
Total Value
$45.67K
Shares Held After
21,264
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
280
Price
$372.93
Total Value
$104.42K
Shares Held After
21,386
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
485
Price
$371.24
Total Value
$180.05K
Shares Held After
21,666
% of Holdings
2.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
644
Price
$370.00
Total Value
$238.28K
Shares Held After
22,151
% of Holdings
2.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
562
Price
$368.76
Total Value
$207.24K
Shares Held After
22,795
% of Holdings
2.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
197
Price
$367.52
Total Value
$72.40K
Shares Held After
23,357
% of Holdings
0.8%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
5,416
Price
$2.50
Total Value
$13.54K
Shares Held After
0
% of Holdings
100.0%
Arcellx, Inc. (ACLX)
Heery Christopher — CHIEF MEDICAL OFFICER
Shares
7,437
Price
$65.51
Total Value
$487.21K
Shares Held After
29,631
% of Holdings
20.1%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
5,704
Price
$5.27
Total Value
$30.06K
Shares Held After
46,100
% of Holdings
11.0%
Clene Inc. (CLNN)
MATLIN DAVID J — Director
Shares
33,333
Price
$6.50
Total Value
$216.66K
Shares Held After
477,824
% of Holdings
7.0%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
1,017
Price
$29.08
Total Value
$29.58K
Shares Held After
154,981
% of Holdings
0.7%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
6,983
Price
$28.44
Total Value
$198.61K
Shares Held After
155,998
% of Holdings
4.3%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
10,000
Price
$28.34
Total Value
$283.40K
Shares Held After
144,846
% of Holdings
6.5%
Atara Biotherapeutics, Inc. (ATRA)
Panacea Innovation Ltd — 10% Owner
Shares
80,554
Price
$6.07
Total Value
$489.02K
Shares Held After
1,324,446
% of Holdings
5.7%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$21.92
Total Value
$4.38M
Shares Held After
1,654,597
% of Holdings
10.8%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
79,590
Price
$17.73
Total Value
$1.41M
Shares Held After
315,978
% of Holdings
20.1%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
4,290
Price
$18.00
Total Value
$77.22K
Shares Held After
216,637
% of Holdings
1.9%
Aktis Oncology, Inc. (AKTS)
Foley Todd — Director
Shares
232,870
Price
$18.00
Total Value
$4.19M
Shares Held After
4,235,403
% of Holdings
5.5%
Aktis Oncology, Inc. (AKTS)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
1,112,777
Price
$18.00
Total Value
$20.03M
Shares Held After
10,260,064
% of Holdings
10.8%
Aktis Oncology, Inc. (AKTS)
GADICKE ANSBERT — 10% Owner
Shares
1,112,777
Price
$18.00
Total Value
$20.03M
Shares Held After
10,260,064
% of Holdings
10.8%
Omeros Corporation (OMER)
Borges David J. — VP, Finance & CAO
Shares
30,000
Price
$12.72
Total Value
$381.60K
Shares Held After
0
% of Holdings
100.0%
Showing 401–450 of 1179 transactions (page 9 of 24)